Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-09-25
2007-09-25
Richter, Johann R. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252100, C514S327000, C514S346000, C514S364000, C544S166000, C544S408000, C546S221000, C546S292000, C548S131000, C548S229000, C558S413000, C558S414000
Reexamination Certificate
active
10466680
ABSTRACT:
Novel compounds of the formula I in which W, X, Y, T, R1and R2are as defined in Patent claim1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic disorders
REFERENCES:
patent: 2361327 (1944-10-01), Sparks
patent: 4761175 (1988-08-01), Schirmer et al.
patent: 2003/0176465 (2003-09-01), Mederski et al.
patent: WO 9916751 (1999-04-01), None
patent: WO 0071510 (2000-11-01), None
patent: WO 0206269 (2002-01-01), None
Ting Su et al: “Design and Synthesis of Glycolic and Mandelic Acid derivatives as Factor Xa Inhibitors” Bioorgnic and Medicinal Chemistry Letters, vol. 11, No. 17, 2001, pp. 2279-2282 XP001069180.
Barnes Christopher
Cezanne Bertram
Dorsch Dieter
Gleitz Johannes
Mederski Werner
Merck Patent GmbH
Millen White Zelano & Branigan P.C.
Richter Johann R.
Sackey Ebenezer
LandOfFree
Phenyl derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenyl derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenyl derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3757595